Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus - Wikidata - wikimedia - TriplyDB

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

http://www.wikidata.org/entity/Q35610369

about

Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells How hyperglycemia promotes atherosclerosis: molecular mechanisms.The Rationale for Insulin Therapy in Alzheimer's Disease The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Carotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases Is there a relationship between mean blood glucose and glycated hemoglobin?Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms Simple non-invasive assessment of advanced glycation endproduct accumulation Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides Extending the spectrum of α-dicarbonyl compounds in vivo.The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin.Characterization of hearing loss in aged type II diabetics Identification of N(omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen.Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes.Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocyt Amadori albumin in diabetic nephropathy Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.Glycation accelerates fibrillization of the amyloidogenic W7FW14F apomyoglobin Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose C-peptide and diabetic neuropathy.New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.Carbonyl stress and diabetic complications.Accumulation of Maillard reaction products in skin collagen in diabetes and aging.Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.Age-related changes in the hepatic microcirculation in mice Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis Glycation products as markers and predictors of the progression of diabetic complications.High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.

P2860

Q24530074-324A3D25-8CBB-4EA4-8681-DA0864A4E741 Q24795988-5E49807B-2897-4279-9F71-C8585357A116 Q26744834-49977D4A-2276-4981-B721-B850247F152D Q26786137-93E3B271-CFAE-4EDB-8EC0-6E539DE94192 Q26796627-5040A9A4-6003-406D-98FC-B4F3ABC56E56 Q27027047-C391C3AD-88F4-4FED-8708-7F166CA69012 Q27694676-E915FE5F-8784-44C4-9692-1A4ADA542D21 Q28271097-39723B8A-3446-4FCB-8AE7-F9EF85D6867F Q28286918-881B42BF-8DA1-4CC0-9BCD-5E358145B48A Q30317115-DF70D62F-A938-4846-B2CE-5A81F30C09E2 Q30328108-B1D17026-E4F8-4A90-B7EA-854E66DD72EF Q30486612-B78811C4-6E1F-4AA4-8018-1ED740E2158B Q30848765-D53BA9BF-ED6C-43A8-B94B-1BC381FBD2B1 Q33409132-8386ADA9-7E18-4619-BB80-AA3DF5222593 Q33530116-9F02AFFF-B12E-43F6-9DF8-B8006BE487A5 Q33633568-E1CC4C37-1665-463E-8F20-5F1B208C6142 Q33822518-8410AD60-FE2D-43FC-82B9-92EE94FB9324 Q33853348-90190AF4-48C5-4019-91BB-70D61021D766 Q33922502-76100ED3-0389-488C-97CB-6E7E9D061AD5 Q34256592-57431771-33B7-4E57-9C64-8524FD81FE08 Q34776819-770D4666-0102-486F-BD3E-63FCAC33F465 Q34802374-08DFA35B-9427-4EDD-A1E9-1BF0195BDA7C Q34878346-7E746E70-6A6C-4208-8F85-EA99E93E4CE4 Q35045662-C97A046E-709F-4F4D-BDCF-78D64F40DFD6 Q35063787-2E809078-CE41-4F17-930F-A00B5EE64953 Q35101624-F75529D0-1263-4DA5-85E5-668A69B58848 Q35207611-84298A45-B62F-4C47-9523-920D27FFC256 Q35508630-245E568E-B561-40E9-83AE-650539153DB1 Q35576070-ABD6B5A4-C107-4097-BAC4-66A78D0AA33F Q35610341-89ACF54D-9938-4D52-BF10-D5E91C69412F Q35739011-648C400F-9E64-4653-9361-AE4A84C0446C Q35748423-454F223E-8968-477F-BA79-803A50CC12C4 Q35809946-6817BB9A-ACFD-443B-893B-754A34878CCB Q35976427-AD8E07E9-6CAF-46C2-A5E7-AED7965FC9E2 Q36030537-19D65C2A-43E6-46F3-82BD-93AD336B13C6 Q36052417-284A0E11-19AD-4B26-B38F-FDEE177096E2 Q36203971-ACC6856A-3C91-4CE6-A4EE-44FA33220BCE Q36318280-5F24160D-57B3-43A2-8862-0C42EDE78FAE Q36608474-7963E3BB-D6EA-463B-BE43-B744874723FB Q36625195-ED9C9447-22FE-4451-989D-04650D6F95EE

P2860

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

http://www.wikidata.org/entity/Q35610369

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Maillard reaction products and ...... in-dependent diabetes mellitus

@ast

Maillard reaction products and ...... in-dependent diabetes mellitus

@en

type

label

Maillard reaction products and ...... in-dependent diabetes mellitus

@ast

Maillard reaction products and ...... in-dependent diabetes mellitus

@en

prefLabel

Maillard reaction products and ...... in-dependent diabetes mellitus

@ast

Maillard reaction products and ...... in-dependent diabetes mellitus

@en

P1433

Q35610369-C821CD17-FCB2-49C4-98B3-4E4822A841A2

P1476

Q35610369-D539AA24-7EC5-4AB6-A9B3-91B4D7C42857

P2093

Q35610369-3BE58045-80C7-4414-A76B-A5F5C7854203

Q35610369-40391D06-1850-4980-B288-9FC513D6414D

Q35610369-561DFD81-19A0-4814-8388-400FF7A26C82

Q35610369-76D63C05-0637-4BA8-8929-1C4E60961E45

Q35610369-C4577C9B-C171-40B1-9A36-133F6115A6D0

Q35610369-C8A829E9-AC04-415A-A2B4-2557B1D000A4

Q35610369-E9133213-28E3-4A78-B4DC-960F59DD9E75

P2860

Q35610369-08A7B824-598A-4FC1-9050-2C27B05E96B7

Q35610369-180AED00-147F-468F-B74E-E3695FAC9C75

Q35610369-20A6965A-20E2-4E48-A87D-3365FB3F04BA

Q35610369-2261FDF1-2F9F-44C6-96B4-075DB63C28C2

Q35610369-2954FBEA-2112-445C-8AE0-E85B8158BFF4

Q35610369-355BDD47-534B-4EFB-AA5A-6C578E5D2B6F

Q35610369-3C7FBB1F-5C62-432E-9F8E-4F3F71AF0C6A

Q35610369-3F5E444F-AA4B-4BBE-913A-4FEF179DC24C

Q35610369-4A666006-702E-4F96-8EFA-F25D90F6595D

Q35610369-4D23FCE3-EF0E-4981-99B2-A951CDB4968C

P304

Q35610369-C6EF1BE0-6559-4C7A-A4C8-1653A1DC67A4

P31

Q35610369-11FA203B-456C-4CF2-BAEE-AECD38150F72

P356

Q35610369-053D4997-EA6F-4945-9B9A-5F4C1474EB35

P407

Q35610369-77FF3BDE-15AA-488B-AF8F-E9AD63F8D15D

P433

Q35610369-D5B0EE66-A49D-4C9C-BEED-5CCECE7BFD4E

P478

Q35610369-18A46509-4897-4315-9D23-765709AAC7F1

P577

Q35610369-D93F9E73-97A7-4A2E-AFC2-1BA7BCCAA28E

P5875

Q35610369-5E0C6FF6-BEDE-4205-8C1B-636685BC5BD7

P698

Q35610369-CF1DE9AB-6987-499B-824C-B98D5EA7EF8B

P921

Q35610369-610C0853-3758-460B-BA21-E8EA22E4FD18

P932

Q35610369-41812373-2379-4695-A35F-F6FFF419D4FE

P356

P1433

Journal of Clinical Investigation

P1476

Maillard reaction products and ...... in-dependent diabetes mellitus

@en

P2093

D G Dyer

http://www.w3.org/2001/XMLSchema#string

D R McCance

http://www.w3.org/2001/XMLSchema#string

J A Dunn

http://www.w3.org/2001/XMLSchema#string

J W Baynes

http://www.w3.org/2001/XMLSchema#string

K E Bailie

http://www.w3.org/2001/XMLSchema#string

S R Thorpe

http://www.w3.org/2001/XMLSchema#string

T J Lyons

http://www.w3.org/2001/XMLSchema#string

P2860

Accelerated age-related browning of human collagen in diabetes mellitus

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.

P304

2470-2478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116482

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1993-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14684178

http://www.w3.org/2001/XMLSchema#string

P698

8514859

http://www.w3.org/2001/XMLSchema#string

P921

P932

443307

http://www.w3.org/2001/XMLSchema#string